CN106065032B - 一新型蛋白结合片段 - Google Patents
一新型蛋白结合片段 Download PDFInfo
- Publication number
- CN106065032B CN106065032B CN201510844478.7A CN201510844478A CN106065032B CN 106065032 B CN106065032 B CN 106065032B CN 201510844478 A CN201510844478 A CN 201510844478A CN 106065032 B CN106065032 B CN 106065032B
- Authority
- CN
- China
- Prior art keywords
- novel combination
- protein fragments
- cea protein
- cea
- combination cea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510844478.7A CN106065032B (zh) | 2015-11-30 | 2015-11-30 | 一新型蛋白结合片段 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510844478.7A CN106065032B (zh) | 2015-11-30 | 2015-11-30 | 一新型蛋白结合片段 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106065032A CN106065032A (zh) | 2016-11-02 |
CN106065032B true CN106065032B (zh) | 2019-07-09 |
Family
ID=57418997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510844478.7A Active CN106065032B (zh) | 2015-11-30 | 2015-11-30 | 一新型蛋白结合片段 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106065032B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012117002A1 (en) * | 2011-03-02 | 2012-09-07 | Roche Glycart Ag | Cea antibodies |
CN104910279A (zh) * | 2015-06-05 | 2015-09-16 | 重庆倍思益生物科技有限公司 | 靶向癌胚抗原的嵌合抗原受体、慢病毒表达载体及其制备方法和应用 |
-
2015
- 2015-11-30 CN CN201510844478.7A patent/CN106065032B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012117002A1 (en) * | 2011-03-02 | 2012-09-07 | Roche Glycart Ag | Cea antibodies |
CN104910279A (zh) * | 2015-06-05 | 2015-09-16 | 重庆倍思益生物科技有限公司 | 靶向癌胚抗原的嵌合抗原受体、慢病毒表达载体及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
A multivalent recombinant antibody fragment specific for carcinoembryonic antigen;Lincidio Perez等;《Biotechnol. Appl. Biochem》;20061231;第43卷;39-48 |
含组氨酸标签的小分子抗体临床应用现状;刘晓等;《中国医药生物技术》;20121231;第7卷(第6期);460-462 |
Also Published As
Publication number | Publication date |
---|---|
CN106065032A (zh) | 2016-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210324074A1 (en) | Affinity matured cd22-specific monoclonal antibody and uses thereof | |
CN107735110A (zh) | 纳米粒子免疫偶联物 | |
CN108738313A (zh) | 新的cd47单克隆抗体及其应用 | |
JP7073487B2 (ja) | 操作された抗体化合物およびこれらの抱合体 | |
CN110494443A (zh) | 用于位点特异性缀合的志贺毒素a亚基效应子多肽、志贺毒素效应子支架和细胞靶向分子 | |
JP7179719B2 (ja) | 抗体、その使用及びそのコンジュゲート | |
CN106659779A (zh) | 双特异性四价抗体及其制造和使用方法 | |
CN108025092A (zh) | 经半胱氨酸取代的免疫球蛋白 | |
US20220098323A1 (en) | High affinity monoclonal antibodies targeting glypican-1 and methods of use | |
KR20240005247A (ko) | 암의 치료 및/또는 예방용 의약 조성물 | |
JP7486538B2 (ja) | 抗psma抗体、その使用及びそのコンジュゲート | |
US20110200525A1 (en) | Vhh antibody fragments for use in the detection and treatment of cancer | |
CN114729041A (zh) | 用于治疗多种实体瘤的靶向b7h3(cd276)的高亲和力纳米抗体 | |
KR20170121215A (ko) | 암의 진단 및 치료를 위한 조성물 및 방법 | |
CN110036028A (zh) | 抗il1-rap抗体 | |
CN105859846B (zh) | 对hpv16 e7具有结合亲和力的多肽及其用途 | |
CN106065032B (zh) | 一新型蛋白结合片段 | |
CN101143902A (zh) | 抗HER2单链抗体-力达霉素强化融合蛋白HER2(Fv-LDM) | |
CN114685664B (zh) | 抗人b淋巴细胞表面抗原cd20的单域抗体及其应用 | |
WO2023076881A1 (en) | Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein | |
CN106729769B (zh) | Tem1特异性荧光探针及其应用 | |
KR20140090295A (ko) | T 세포 특이적인 인간화 단일조각항체 전달체 | |
CN110269943A (zh) | 一种靶向于egfr的抗体-药物偶联物及其制备方法与应用 | |
CN108187065A (zh) | 抗5t4抗体与美登素衍生物dm4偶联复合物及制备方法和用途 | |
CN108721641A (zh) | 抗cd30抗体与力达霉素的抗体药物偶联物、制备方法及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Luo Qin Inventor after: Qu Lin Inventor after: Yu Xin Inventor before: Luo Qin Inventor before: Liu Xiao Inventor before: Qu Lin Inventor before: Wang Mingrong |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170721 Address after: 610041, B, building B-19, No. 1, high tech incubator Park, South extension Road, Tianfu Road, Sichuan, Chengdu Applicant after: Chengdu Kun Kun Biological Technology Co., Ltd. Address before: 610041, B, building B-17, No. 1, high tech incubator Park, South extension Road, Tianfu Road, Sichuan, Chengdu Applicant before: Chengdu Jin Huikang bio molecule Technology Co Ltd |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200312 Address after: 610200 Chengdu, Sichuan, Shuangliu District, West Hang Kong Economic Development Zone Airport three Road 999. Patentee after: Chengdu nurit Medical Technology Co., Ltd Address before: 610041 B-19, block B, building 1, new hatching garden, South extension line, Tianfu Road, Chengdu, Sichuan Patentee before: Chengdu Jinkun Biotechnology Co.,Ltd. |